English
Specials
    Upgrade

    Moneycontrol

    Budget 2023Budget 2023

    PARTNERS

    • Tata AIA Life Insurance
    • Hafele
    • Motilal Oswal
    • SMC Global Securities Limited
    • SBI Life
    • DSP Mutual Fund
    Upcoming Event : LeapToUnicorn - mentoring, networking and fundraising for startups. Register now
    you are here: HomeNewsBusinessMoneycontrol Research

    IPCA Labs guidance should move investor focus beyond HCQS, accumulate

    There is much more to IPCA Labs than the HCQS opportunity. Its FY21 guidance reflects that.

    Anubhav Sahu
    July 06, 2020 / 05:32 PM IST
    IPCA Labs guidance should move investor focus beyond HCQS, accumulate

    Bharat Immunologicals & Biologicals Corporation | In the last four months, the stock price has risen 444 percent to Rs 31.34 per share from Rs 5.76 per share on March 27, 2020.

    PRO Only Highlights
    -      Quarterly performance largely backed by improved realisations
    -      Medium-term triggers China plus and protectionist measures for tyre industry
    -      Valuations not inexpensive; but improved medium-term outlook

    Anubhav Sahu Moneycontrol Research - Strong HCQS sales in Q1 FY21 though uncertainty increases for future demand - Strong operating performance and guidance brings focus beyond HCQS - FY21 guidance for 15% plus sales growth and margin expansion of 150 bps - Resolution of US FDA import alerts and environment clearances - key near term watch IPCA Labs (CMP: Rs 1,662, Market cap: Rs 21,008 crore) had been on the radar of investors as the anti-malarial drug HCQS (hydroxychloroquine sulphate) was seen as a drug of choice...

    • PRO Panorama

      Moneycontrol Pro Panorama | MPC plays it safe, more rate hikes coming?

      Feb 8, 2023 / 03:17 PM IST

      In today’s edition of Moneycontrol Pro Panorama: No end to rate hike cycle, make the most of market volatility, puzzling economi...

      Read Now
    • PRO Weekender

      Moneycontrol Pro Weekender: The elephant in the room

      Feb 4, 2023 / 11:20 AM IST

      The well-crafted and well-delivered budget got many ‘wows’, but Mr Market’s worry lines are not yet gone

      Read Now

    To read the full story, Subscribe to Moneycontrol PRO

    Access the exclusive stories, weekly investment ideas and daily technical calls in an Ad free experience

    View Plans

    Already a member? Sign in

    Limited Period offer on Moneycontrol PRO. Subscribe to PRO and get up to

    50% OFF

    What Do You Get

    • Ad free experience

      Experience a non-intrusive navigation and faster response in the ad free mode

    • Sharpest Opinions

      Access to 230+ exclusive stories per month from our editorial and Experts

    • +

      Have a Global edge with access to content from world renowned experts and journalist

    • Actionable Insights

      Access to 40+ weekly investment ideas including 4 daily technical calls

    • Virtual Events

      Exclusive access to live webinars from market experts on trading and investment strategies

    • Newsletters

      Daily and weekly insights bundled and sent to your inbox to keep you ahead in the race.

    View Offers

    Get upto 50% discount on limited period offers